Chronic Administration of the Glucagon-Like Peptide-1 Analog, Liraglutide, Delays the Onset of Diabetes and Lowers Triglycerides in UCD-T2DM Rats - Concepedia

Concepedia

Publication | Open Access

Chronic Administration of the Glucagon-Like Peptide-1 Analog, Liraglutide, Delays the Onset of Diabetes and Lowers Triglycerides in UCD-T2DM Rats

DOI Full Paper Access

73

Citations

33

References

2010

Year

Bethany P. Cummings, Kimber L. Stanhope, James L. Graham, Denis G. Baskin, Steven C. Griffen, Cecilia Nilsson, Anette Sams, Lotte Bjerre Knudsen, Kirsten Raun, Peter J. Havel

Abstract

Liraglutide treatment delays the development of diabetes in UCD-T2DM rats by reducing energy intake and body weight, and by improving insulin sensitivity, improving lipid profiles, and maintaining islet morphology.

References

	Year	Citations

Page 1